Takeda
Tokyo, Japan (U.S. headquarters: Cambridge, MA)
Takeda is a global biopharmaceutical company with a strong presence in immunology, gastroenterology, and rare diseases. Their immunology portfolio includes subcutaneous immunoglobulin products and biologics for inflammatory bowel disease. Takeda is also a major producer of plasma-derived therapies.
Drugs
Hub Program — Takeda Patient Support
- ✓Insurance verification and benefits investigation
- ✓Prior authorization and appeals assistance
- ✓Copay assistance for eligible commercially insured patients
- ✓Patient assistance program for qualifying patients
- ✓Nurse educator support for self-infusion training
Patient Assistance
Copay Assistance
Takeda offers copay programs for commercially insured patients on Gammagard Liquid, HyQvia, Cuvitru, and Entyvio.
Patient Assistance Program (PAP)
Takeda Patient Assistance Program provides free medication to eligible uninsured or underinsured patients.
Denied a Takeda Drug?
Ellen can decode your denial, identify the specific reason, and generate a personalized appeal letter — free.